Partners Group has bought a controlling stake in Australian early childhood education provider Guardian Early Learning Group from Navis Capital Partners at a post-deal valuation of A$440 million ($313 million)
Australia’s Future Fund has lowered its private equity allocation slightly and boosted its cash holdings, reflecting concerns over increased risk due to changes in lending and public policy across markets.
Australia-based pet services business Greencross has confirmed it received and rejected a buyout offer from TPG Capital worth around A$720 million ($507 million).
J.C. Flowers has agreed to buy the Australia and Japan businesses of Chi-X Global Holdings, an alternative equity trading platform that competes with primary exchanges, as well as the company’s Hong Kong-based technology services unit.
New Zealand Venture Investment Fund (NZVIF) and Taiwan’s National Development Fund (NDF) will each commit $7.5 million to a cross-border technology-focused fund.
Anchorage Capital Partners has spoken out for the first time about the demise of its former portfolio company, Dick Smith Electronics, for which the Australian GP has attracted much criticism.
Evonik Venture Capital, the VC arm of German industrial group Evonik, has invested an undisclosed amount in Chinese VC firm GRC Managers' SinoGreen Fund III (GRC III).
The demise of Dick Smith Electronics has prompted criticisms of Anchorage Capital Partners' handling of the business and left investors questioning the quality of PE-backed IPOs in Australia
L Capital, a private equity firm sponsored by luxury goods giant LVMH, will merge with consumer-focused GP Catterton to form L Catterton.
CHAMP Ventures acquires New Zealand outdoor apparel and equipment supplier Macpac with a view to replicating the success it has enjoyed with Lorna Jane
CHAMP Ventures has agreed to take a significant majority stake in Macpac Group, a New Zealand-based outdoor apparel and equipment supplier.
Australian actor Hugh Jackman has invested in bootmaker R.M. Williams, alongside majority shareholder L Capital Asia.
IFM Investors has agreed to sell Australia-headquartered renewable energy platform Pacific Hydro to China’s State Power Investment Corporation (SPIC).
First State Super teams up with local VC player H2 Ventures to back Australia financial technology start-ups
From Australia to China and buyouts to venture, industry participants give their perspectives on the year to come for fundraising, investments, and exits
Atlassian, an enterprise software company founded in Sydney by two Australian entrepreneurs, has raised $462 million in its NASDAQ IPO after raising the price of the offering once again.
Blue Sky Venture Capital, a division of Australia-based Blue Sky Alternative Investments, will raise a A$200 million ($144 million) fund focused on later-stage local start-ups.
Paine & Partners, which focuses on the global food and agribusiness industry, has acquired a majority stake in AgBiTech, an Australia-based producer of biological insecticides for crops.
First State Super has teamed up with VC firm H2 Ventures to support financial technology start-ups. The Australian superannuation fund expects to deploy around A$250 million ($182 million) in technology innovation.
Pacific Equity Partners took about 12 months to reel in cleaning and catering contractor Spotless, but swift improvements resulted in a 2.4x return within the two years
Infrastructure privatizations in Australia are commanding ever higher price tags by virtue of their perceived quality and relative rarity. It is increasingly difficult for smaller investors to compete
The Australian government has introduced a range of measures to boost local innovation and entrepreneurship.
Atlassian, an enterprise software company founded in Sydney by two Australian entrepreneurs, has increased the size of its NASDAQ IPO to as much as $440 million.
Archer Capital has agreed to sell Healthe Care, Australia’s third-largest private hospital group, to China-based Luye Medical Group, for $688 million. CITIC Private Equity is a shareholder in the company’s Hong Kong-listed affiliate, Luye Pharma.